Keyword: Food and Drug Administration (FDA)
Lawmakers in several states are seeking to fix a problem that keeps some patients from accessing clinical trials.
The Trump administration continued its series of moves this week aimed at lowering prescription drug prices as it released new guidance on Friday.
As part of the Trump administration's ongoing efforts on drug prices, the FDA will convene a working group to investigate importing certain medications.
FDA Director Scott Gottlieb announced a Biosimilars Action Plan as part of a broader plan to address drug prices, plus other healthcare headlines.
Data breaches cost healthcare companies $408 per record, almost twice as much as the financial industry. Plus digital health took in $4.9B this year.
Cedars-Sinai announces nine new startups inducted into its accelerator and a study shows a 7% error rate with speech recognition software.
New AHIP CEO Matt Eyles spent more than a decade crafting public policy for drugmakers. Now he's making drug prices his top priority.
Pharmacies and physicians at hospitals across the U.S. are still grappling with an opioid crisis based on shortages, rather than overuse and abuse.
GW Pharma believes it will be able to begin marketing its drug by this fall and other healthcare news from around the web.
The Food and Drug Administration needs access to more data as it rethinks what a clinical trial looks like, said Commissioner Scott Gottlieb.